BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35159368)

  • 1. Treatment of Pheochromocytoma Cells with Recurrent Cycles of Hypoxia: A New Pseudohypoxic In Vitro Model.
    Helm J; Drukewitz S; Poser I; Richter S; Friedemann M; William D; Mohr H; Nölting S; Robledo M; Bornstein SR; Eisenhofer G; Bechmann N
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma.
    Wang Y; Liu B; Li F; Zhang Y; Gao X; Wang Y; Zhou H
    Front Endocrinol (Lausanne); 2023; 14():1274239. PubMed ID: 37867526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas.
    Bechmann N; Moskopp ML; Ullrich M; Calsina B; Wallace PW; Richter S; Friedemann M; Langton K; Fliedner SMJ; Timmers HJLM; Nölting S; Beuschlein F; Fassnacht M; Prejbisz A; Pacak K; Ghayee HK; Bornstein SR; Dieterich P; Pietzsch J; Wielockx B; Robledo M; Qin N; Eisenhofer G
    Endocr Relat Cancer; 2020 Nov; 27(11):625-640. PubMed ID: 33112842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells.
    Bechmann N; Poser I; Seifert V; Greunke C; Ullrich M; Qin N; Walch A; Peitzsch M; Robledo M; Pacak K; Pietzsch J; Richter S; Eisenhofer G
    Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31035382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible Factor 2α: A Key Player in Tumorigenesis and Metastasis of Pheochromocytoma and Paraganglioma?
    Bechmann N; Eisenhofer G
    Exp Clin Endocrinol Diabetes; 2022 May; 130(5):282-289. PubMed ID: 34320663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opposing effects of HIF1α and HIF2α on chromaffin cell phenotypic features and tumor cell proliferation: Insights from MYC-associated factor X.
    Qin N; de Cubas AA; Garcia-Martin R; Richter S; Peitzsch M; Menschikowski M; Lenders JW; Timmers HJ; Mannelli M; Opocher G; Economopoulou M; Siegert G; Chavakis T; Pacak K; Robledo M; Eisenhofer G
    Int J Cancer; 2014 Nov; 135(9):2054-64. PubMed ID: 24676840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development.
    Mohr H; Ballke S; Bechmann N; Gulde S; Malekzadeh-Najafabadi J; Peitzsch M; Ntziachristos V; Steiger K; Wiedemann T; Pellegata NS
    Cancers (Basel); 2021 Jan; 13(1):. PubMed ID: 33401758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudohypoxic pheochromocytomas and paragangliomas dominate in children.
    Redlich A; Pamporaki C; Lessel L; Frühwald MC; Vorwerk P; Kuhlen M
    Pediatr Blood Cancer; 2021 Jul; 68(7):e28981. PubMed ID: 33682326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction.
    Jochmanová I; Yang C; Zhuang Z; Pacak K
    J Natl Cancer Inst; 2013 Sep; 105(17):1270-83. PubMed ID: 23940289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pheochromocytomas: the (pseudo)-hypoxia hypothesis.
    Favier J; Gimenez-Roqueplo AP
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):957-68. PubMed ID: 21115164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations.
    Bernardo-Castiñeira C; Valdés N; Celada L; Martinez ASJ; Sáenz-de-Santa-María I; Bayón GF; Fernández AF; Sierra MI; Fraga MF; Astudillo A; Jiménez-Fonseca P; Rial JC; Hevia MÁ; Turienzo E; Bernardo C; Forga L; Tena I; Molina-Garrido MJ; Cacho L; Villabona C; Serrano T; Scola B; Chirivella I; Del Olmo M; Menéndez CL; Navarro E; Tous M; Vallejo A; Athimulam S; Bancos I; Suarez C; Chiara MD
    J Clin Endocrinol Metab; 2019 Nov; 104(11):5673-5692. PubMed ID: 31216007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Insights into the Nuclear Imaging Phenotypes of Cluster 1 Pheochromocytoma and Paraganglioma.
    Taïeb D; Pacak K
    Trends Endocrinol Metab; 2017 Nov; 28(11):807-817. PubMed ID: 28867159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncometabolite induced primary cilia loss in pheochromocytoma.
    O'Toole SM; Watson DS; Novoselova TV; Romano LEL; King PJ; Bradshaw TY; Thompson CL; Knight MM; Sharp TV; Barnes MR; Srirangalingam U; Drake WM; Chapple JP
    Endocr Relat Cancer; 2019 Jan; 26(1):165-180. PubMed ID: 30345732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro oncogenic effects of HIF2A mutations in pheochromocytomas and paragangliomas.
    Toledo RA; Qin Y; Srikantan S; Morales NP; Li Q; Deng Y; Kim SW; Pereira MA; Toledo SP; Su X; Aguiar RC; Dahia PL
    Endocr Relat Cancer; 2013 Jun; 20(3):349-59. PubMed ID: 23533246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHEOCHROMOCYTOMA: A GENETIC AND DIAGNOSTIC UPDATE.
    Mercado-Asis LB; Wolf KI; Jochmanova I; Taïeb D
    Endocr Pract; 2018 Jan; 24(1):78-90. PubMed ID: 29144820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma.
    Peng S; Zhang J; Tan X; Huang Y; Xu J; Silk N; Zhang D; Liu Q; Jiang J
    Front Endocrinol (Lausanne); 2020; 11():586857. PubMed ID: 33329393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway.
    Pang Y; Yang C; Schovanek J; Wang H; Bullova P; Caisova V; Gupta G; Wolf KI; Semenza GL; Zhuang Z; Pacak K
    Oncotarget; 2017 Apr; 8(14):22313-22324. PubMed ID: 28423608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Landscape of Pheochromocytoma and Paraganglioma.
    Jochmanova I; Pacak K
    Trends Cancer; 2018 Jan; 4(1):6-9. PubMed ID: 29413423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models.
    Bullova P; Cougnoux A; Abunimer L; Kopacek J; Pastorekova S; Pacak K
    Oncotarget; 2016 Jun; 7(26):40531-40545. PubMed ID: 27244895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GIPC2 is an endocrine-specific tumor suppressor gene for both sporadic and hereditary tumors of RET- and SDHB-, but not VHL-associated clusters of pheochromocytoma/paraganglioma.
    Dong Y; Huang Y; Fan C; Wang L; Zhang R; Li W; Guo Z; Wang D; Zheng Z
    Cell Death Dis; 2021 May; 12(5):444. PubMed ID: 33947839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.